Ybañez, Eddan D.

HRN: 15-59-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/21/2026
01/28/2026
PO
10mL
TID
Intestinal Amoebasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: